NASDAQ$OMCL

Omnicell Inc. · Q2 2021 earnings

Q2 2021 earnings · · Investor relations

Briefing

Reported record revenues and non-GAAP net income per diluted share.

Omnicell announced strong financial results for the second quarter of 2021, with record revenues of $273 million and GAAP net income per diluted share of $0.43. The company's performance reflects robust demand for its solutions and services.

  • Achieved record revenue in the second quarter.
  • Reported record non-GAAP net income per diluted share.
  • Advanced Services portfolio continues to gain momentum in the market.
  • Announced intent to acquire FDS Amplicare to strengthen Advanced Services portfolio.

Headline financials

Total Revenue

$273M

Previous: $200M+36.6%
EPS (adj)

$0.97

Previous: $0.37+162.2%
Non-GAAP EBITDA

$61M

No prior period
Capital Expenditures

-$11.1M

Previous: -$13.2M+16.2%
Free Cash Flow

$9.36M

Previous: -$17.5M+153.4%
Net Income

$20.4M

Previous: -$4.3M+575.1%
Operating Income

$28.9M

Previous: -$6.99M+513.6%
Gross Profit

$136M

Previous: $83.2M+63.8%
Cash & Equivalents

$614M

Previous: $134M+359.8%
Total Assets

$1.96B

Previous: $1.22B+60.4%
Stock-Based Comp

$13M

Previous: $11.4M+14.9%

Revenue & EPS history

Omnicell · Revenue · Quarterly

$273M

Q2 2021+36.6%vs Q2 2020
Beat estimate in 13 of 16 quarters(81%)
ActualEstimate

Revenue by segment

Omnicell · $197M total across 1 segment · Q2 2021

  • Product revenues
    $197M+41.7%

Forward guidance

For the third quarter of 2021, Omnicell expects total revenues to be between $281 million and $286 million and non-GAAP earnings to be between $0.89 and $0.94 per share.

Tailwinds

  • Total revenues to be between $281 million and $286 million.
  • Product revenues to be between $202 million and $205 million.
  • Service revenues to be between $79 million and $81 million.
  • Non-GAAP EBITDA to be between $57 million and $60 million.
  • Non-GAAP earnings to be between $0.89 and $0.94 per share.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2021

Historical avgQ2 2021

+0.7%

Avg return

Earnings day

+1.6%

Avg return

5 days after

+4.7%

Avg return

30 days after

55%

36 / 65 earnings

Positive

+34.3%

Q2 2024

Best reaction

-29.4%

Q3 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.2%+13.7%+18.8%
Q4 2025-16.3%-16.5%-11.5%
Q3 2025+13.4%+16.7%+23.5%
Q1 2025-16.0%-15.4%+1.2%
Q4 2024-11.2%-7.1%-16.7%
Q3 2024+21.2%+20.9%+16.1%
Q2 2024+34.3%+41.6%+52.3%
Q1 2024+10.9%+11.5%+19.9%
Q4 2023-15.6%-11.9%-12.0%
Q3 2023-14.9%-13.9%-5.5%
Q2 2023+2.3%+2.9%-10.0%
Q1 2023+8.9%+7.1%+18.6%
Q4 2022+7.9%+6.6%+6.4%
Q3 2022-29.4%-35.9%-33.4%
Q2 2022-2.1%-5.6%-10.6%
Q1 2022+1.2%+5.9%+4.7%
Q4 2021-9.6%-18.4%-11.5%
Q3 2021+2.2%+1.6%+1.5%
Q2 2021-1.1%+0.4%+7.1%
Q1 2021+1.8%-1.5%-2.4%
Q4 2020+7.0%+8.9%+6.5%
Q3 2020+2.3%+2.9%+27.0%
Q2 2020+9.1%+5.5%+2.7%
Q1 2020-6.1%-12.3%-0.5%
Q4 2019-1.4%+2.3%-4.5%
Q3 2019-3.7%-1.9%+7.4%
Q2 2019+6.7%+5.4%+0.6%
Q1 2019+0.7%+3.8%+4.7%
Q4 2018+17.9%+21.0%+28.0%
Q3 2018+6.1%+15.2%+18.8%
Q2 2018+13.7%+13.0%+29.5%
Q1 2018+1.6%-0.1%+5.3%
Q4 2017-6.2%-9.8%-12.9%
Q3 2017-6.4%-8.2%-7.6%
Q2 2017+12.5%+16.3%+12.1%
Q1 2017-3.2%-1.7%+0.0%
Q4 2016-0.7%+1.0%+4.5%
Q3 2016-6.3%-6.8%+3.2%
Q2 2016+6.8%+4.7%+3.4%
Q1 2016+3.9%
Q4 2015-1.0%
Q3 2015-10.5%
Q2 2015-8.8%
Q1 2015-2.6%
Q4 2014+5.3%
Q3 2014+9.7%
Q2 2014-3.9%
Q1 2014+0.4%
Q4 2013+8.9%
Q3 2013-1.4%
Q2 2013+8.7%
Q1 2013+7.6%
Q3 2010-1.3%
Q4 2012+13.4%
Q3 2012+12.2%
Q2 2012+0.9%
Q1 2011-0.3%
Q1 2012+4.8%
Q4 2011+2.6%
Q4 2009+2.6%
Q3 2011-0.7%
Q2 2010-16.9%
Q2 2011-16.9%
Q4 2010-16.9%
Q1 2010+7.0%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro